Found 4 results
Name | Type of Offering | Accepted Date |
---|---|---|
Enalare Therapeutics Inc.
See All Filings
|
D | 2022-02-07 16:36:47 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001835701
Filed Document
0001835701-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-02-07 16:36:47
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Enalare Therapeutics Inc.
See All Filings
|
D/A | 2020-12-21 13:48:32 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001835701
Filed Document
0001835701-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-12-21 13:48:32
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Enalare Therapeutics Inc.
See All Filings
|
D | 2020-12-11 14:38:19 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001835701
Filed Document
0001835701-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-12-11 14:38:19
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Enalare Therapeutics Inc.
See All Filings
|
D | 2022-08-15 16:30:11 |
Amount To Be Raised
$55,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001835701
Filed Document
0001835701-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-08-15 16:30:11
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|